TriangleNCT05556616 · MORE INFO
Limitations, agreements, and source contact
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- certain Agreement
- pi Sponsor Employee
- false
- restrictive Agreement
- true
- limitations And Caveats
- description
- Study was terminated early by sponsor for strategic reasons. No participants were enrolled in Group 2 Arm 4: modakafusp alfa + bortezomib \& Group 3 arms. Data for endpoints related to PFS, OS, DOR, TTP, TTNT, EFS, TTR, \& MRD were not collected as planned \& hence not reported.
- point Of Contact
- USMedInfo@tevapharm.com
- organization
- Teva U.S. Medical Information
- phone
- 1-888-483-8279
- title
- Study Director
Complete source fields
- certain Agreement
- pi Sponsor Employee
- false
- restrictive Agreement
- true
- limitations And Caveats
- description
- Study was terminated early by sponsor for strategic reasons. No participants were enrolled in Group 2 Arm 4: modakafusp alfa + bortezomib \& Group 3 arms. Data for endpoints related to PFS, OS, DOR, TTP, TTNT, EFS, TTR, \& MRD were not collected as planned \& hence not reported.
- point Of Contact
- USMedInfo@tevapharm.com
- organization
- Teva U.S. Medical Information
- phone
- 1-888-483-8279
- title
- Study Director
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice